Delivery Order SPE2DB20D3103-SPE2DB25FL3M9

Award Date 10/11/24
Potential Completion Date 10/15/24
Potential Value $99K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,372.83 firm fixed-price delivery order is for the supply of 1,200,000 units of 2ml Bicillin L-A, a prescription antibiotic medication. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 1,200,000 units of the drug Bicillin L-A in 2 mL vials. The $1,072.54 firm fixed price delivery order has a completion date of September 27, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,208.75 firm fixed-price contract is for the delivery of 1,200,000 units (2 ml) of the antibiotic medication Bicillin L-A. The contract has an ultimate completion date of October 28, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,072.54 Firm Fixed Price delivery order is for 1,200,000 units of the antibiotic medication Bicillin L-A, with a performance period ending on July 18, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for...
This federal contract award, valued at $105,967.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a medication, with an ultimate completion date of October 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $76,391.25 firm fixed-price delivery order contract is for the supply of 1,200,000 units of Bicillin L-A, a prescription antibiotic medication, with a completion date of November 5, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $5,590.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin-based medication, with a completion date of February 6, 2025. This award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a prescription antibiotic medication, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,607.08, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 19, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 1,200,000 units of Bicillin L-A, a medication, for a firm fixed price of $1,789.53. The award, with a completion date of November 8, 2024, is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 2,400,000 units of the antibiotic drug Bicillin L-A in 4ml vials. The fixed-price delivery order, valued at $16,456.17, has a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, worth up to $999,999,999.00 through December 2025, to provide a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL3M9
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $99,329.36, is for the delivery of 1,200,000 units of the antibiotic medication Bicillin L-A in 2 mL vials. The contract has a firm fixed price and an ultimate completion date of October 15, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:04 AM